Drug performance and price data envelopment analysis.docVIP

 PAGE \* MERGEFORMAT 8 Drug performance and price data envelopment analysis Abstract Application of data envelopment analysis (DEA) drug prices with the same type of antibiotic efficacy and safety evaluation of the efficiency. Select the appropriate input and output indicators, with the DEA method to calculate a variety of species compared with other relative efficiency index, and thus determine its price and performance are the same. Keywords: data envelopment analysis; relative efficiency; Evaluation Drug prices and its performance, that is, the study of prices of drugs have been of concern to the study of economics one of the issues. Doctors in the choice of drug treatment, not only to consider the effectiveness of drugs, safety, also have to consider the economic factors that prevent patients from receiving the best therapeutic effect and minimal financial burden. Cost - benefit analysis (CBA) is a kind of results to a specific clinical purpose metrics and a basis for calculating and comparing the cost-benefit ratio, or earnings per unit cost of economic analysis to select to a certain the least expensive treatment when the treatment regimen. However, the clinical course of treatment, input and output are often multi-index, and returns to take into account not only the treatment of diseases, but also to take into account the treatment-induced side effects, namely, the occurrence of adverse reactions, because the event of a side effect, will increase the treatment of costs. At the same time the patient admitted to the severity of disease will certainly have an impact on the results. This study uses data envelopment analysis (DEA) method, similar antibiotic drugs, the efficiency of price and performance evaluation, the aim of finding effective treatments. The establishment of an indicator system Pairs of input and output evaluation of drug effects, the choice of indicators must be able to objectively reflect the course o